Webcasts from the ECCO'18 Scientific Programme

"Science improving patients' lives."

Webcasts from the Scientific Programme of the 13th Congress of ECCO will be uploaded as they become available.


The scientific programme is structured around basic science, translational medicine and clinical sessions, given by some of the world’s top specialists. It also includes oral presentations of the best abstracts, the announcement of ECCO Fellowships and Grants and summary presentations of new ECCO Guidelines. 

Select a Scientific Session below to view a list of available content.

Scientific Session 1: Exploring IBD over Time

Can we diganose pre-symptomatic IBD?

Joana Torres, Lisbon, Portugal

► Watch now


OP001: Gut barrier dysfunction– a primary defect in twins with Crohn’s Disease predominantly caused by genetic predisposition

J. Halfvarson, Örebro, Sweden

► Watch now

View Abstract 


OP002: Assessment of disease activity patterns during the first 10 years after diagnosis in a population-based Crohn’s Disease cohort shows a quiescent disease course for a substantial proportion of the population

D. Wintjens, Maastricht, Netherlands

► Watch now

View Abstract


OP003: Temporal changes in immune pathways with consecutive biological therapies as measured by serum proteomics

M. de Bruyn, Leuven, Belgium

► Watch now

View Abstract


Evolution of disease pathways over time in CD - early versus late disease

Gerhard Rogler, Zurich, Switzerland 

► Watch now

 

Scientific Session 2: Novel treatment strategies

Combining new drugs with different mechanisms

Shomron Ben-Horin, Ramat Gan, Israel

► Watch now


OP005: Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn’s Disease patients

A. Strik, Amsterdam, Netherlands

► Watch now

View Abstract


OP006: Apremilast for active Ulcerative Colitis: A phase 2, randomised, double-blind, placebo-controlled induction study

Silvio Danese, Milan, Italy

► Watch now

View Abstract


Small molecules are back

Laurent Peyrin-Biroulet, Vandeouvre-Les-Nancy, France

► Watch now

 

Scientific Session 3: Returning to a normal life with IBD

Sexual dysfunction in IBD patients

Eugeni Domènech, Badalona, Spain

► Watch now


How to prevent disability

Jean-Frédéric Colombel, New York City, United States

► Watch now


OP007: Detection of mucosal healing with a serum marker panel in adalimumab treated patients with Ulcerative Colitis

M. de Bruyn, Leuven, Belgium
Silvio Danese, Milan, Italy

► Watch now

View Abstract


Patient perspective on treatment goals

Corey Siegel, Lebanon, United States

► Watch now

 

Scientific Session 4: The future of IBD diagnosis and disease prediction

ECCO-ESGAR Guidelines: Present and future of diagnostic techniques for IBD

Jaap Stoker, Amsterdam, The Netherlands

Christian Maaser, Lueneburg, Germany

► Watch now


OP009: A combination of clinical, serological and genetic factors predicts complicated disease course in paediatric-onset Crohn’s disease: results from a population-based study.

H. Sarter, Lille, France

► Watch now

View Abstract


OP010: Shallow whole genome sequencing predicts the future cancer risk of low grade dysplastic lesions arising in Ulcerative Colitis

I. Al Bakir, London, United Kingdom

► Watch now

View Abstract


OP011: Integration of whole exome sequencing and RNA sequencing of intestinal biopsies in Inflammatory Bowel Disease identifies inflammation dependent effects

R. Barbieri, Groningen, Netherlands

► Watch now

View Abstract


OP013: HLA-DQA1 contributes to the development of antibodies to anti-TNF therapy in Crohn's Disease

A. Sazonovs, Hinxton, United Kingdom

► Watch now

View Abstract


OP014: Analysis of 1792 gut metagenomes reveals microbial treatment targets for Inflammatory Bowel Disease and irritable bowel syndrome

A. Vich Vila, Groningen, Netherlands

► Watch now

View Abstract


Integration of "omics" and potential for clinical practice

Claudio Fiocchi, Cleveland, United States

► Watch now

 

Scientific session 5: New opportunities for IBD care and research

Point of care tests

Ann Gils, Leuven, Belgium

► Watch now


Web-based registries

Pascal Juillerat, Bern, Switzerland

► Watch now


Can the patient become an investigator?

Germari Bianchi, Milan, Italy

► Watch now

 

Scientific session 6: Best perioperative management of IBD

Get your patient fit for surgery

Paulo Kotze, Curitiba, Brazil; Calgary, Canada
Peter Irving, London, United Kingdom

► Watch now


OP016: Need for primary abdominal surgery, but not repeated surgery, has decreased – a nationwide study of temporal trends in Crohn surgery in Sweden 1990-2014

D. Kalman, Linköping, Sweden

► Watch now

View Abstract


Enhanced postoperative recovery pathways

Gionata Fiorino, Milan, Italy
Antonino Spinelli, Milan, Italy

► Watch now


OP017: Transanal minimally-invasive proctectomy with ileal pouch anal anastomosis (Ta-IPAA) in patients with Ulcerative Colitis: A cohort study from the TaTME international database

G. Pellino, Naples, Italy

► Watch now

View Abstract


OP018: High-Fat diet and inflammation drive intestinal fibrosis enhancing epithelial-mesenchymal transition through the activation of S1P3 signaling

Sudharshan Elangovan, Rozzano, Italy

► Watch now

View Abstract


Preventive strategy after resection surgery in CD

Pierre Michetti, Lausanne, Switzerland

► Watch now

 

Scientific session 7: ECCO Fellowships and Grants

OP019: In Faecal Microbiota Transplantation (FMT) for Ulcerative Colitis, fusobacterium is associated with lack of remission, while metabolic shifts to starch degradation and short chain fatty acid production are associated with remission (FOCUS study)

S. Paramsothy, Sydney, Australia

► Watch now

View Abstract

 

Scientific session 8: IBD Horizons

OP022: Rapidity of clinical and laboratory improvements following upadacitinib induction treatment: Data from the CELEST study

S. Schreiber, Kiel, Germany

► Watch now

View Abstract


OP023: A phase 3b open-label multicentre study (VERSIFY) of the efficacy of vedolizumab on endoscopic healing in Moderately to Severely active Crohn's Disease (CD)

S. Danese, Milan, Italy

► Watch now

View Abstract


OP024: Long-term safety and efficacy of the anti-MAdCAM monoclonal antibody SHP647 for the treatment of Crohn’s Disease: The OPERA II study

G.R. D´Haens, Amsterdam, Netherlands

► Watch now

View Abstract


OP025: Comparative effectiveness of vedolizumab and tumour necrosis factor–antagonist therapy in Crohn’s Disease: A multicentre consortium propensity score–matched analysis

P.S. Dulai, San Diego, La Jolla, United States

► Watch now

View Abstract


OP026: Comparative effectiveness of vedolizumab and TNF-antagonist therapy in Ulcerative Colitis: A multicentre consortium propensity score–matched analysis

P.S. Dulai, San Diego, La Jolla, United States

► Watch now

View Abstract

 

Scientific session 9: Basic Science: Evolving concepts of IBD pathogenesis

Pathogenesis of fistulising IBD

Michael Scharl, Zurich, Switzerland

► Watch now


OP027: SUCNR1 receptor mediates intestinal fibrosis

J. Cosin-Roger, Valencia, Spain

► Watch now

View Abstract


Stress-induced controllers of intestinal inflammatory reactions

Hermona Soreq, Jerusalem, Israel

► Watch now


How the gut speaks to the liver: Novel insights from PSC pathogenesis

Herbert Tilg, Innsbruck, Austria

► Watch now

 

Scientific session 10: Growing up with IBD safely

Safe use of drugs in paediatric and elderly populations

Gigi Veereman, Brussels, Belgium
Pieter Hindryckx, Ghent, Belgium

► Watch now


OP031: Clinical effectiveness, safety and immunogenicity of anti-TNF therapy in Crohn’s Disease: 12 month data from the PANTS study

N.A. Kennedy, Exeter, United Kingdom

► Watch now

View Abstract


OP032: Outcome of pregnancies in female IBD patients treated with vedolizumab

A. Moens, Leuven, Belgium

► Watch now

View Abstract


ESPGHAN-ECCO Guidelines: Update on Paediatric UC Treatment

Dan Turner, Jerusalem, Israel
Richard Russell, Glasgow, United Kingdom

► Watch now


OP034: The initiation of thiopurines in elderly patients with Inflammatory Bowel Disease is associated with an increased risk of adverse effects: A case-control study of the eneida registry

M. Calafat, Palma, Spain

► Watch now

View Abstract


OP035: NUDT15 variants contribute to thiopurine-induced myelosuppression in European populations

G. Walker, Exeter, United Kingdom

► Watch now

View Abstract


Monitoring and improving safety of new agents

Miguel Regueiro, Pittsburgh, United States

► Watch now

 

Scientific session 11: Colorectal Cancer in IBD

Molecular basis of dysplasia in IBD - clues for cancer prevention therapies?

Laurence Egan, Galway, Ireland

► Watch now


OP036: Long-term risk of advanced neoplasia after colonic low-grade dysplasia in patients with Inflammatory Bowel Disease: A nationwide cohort study

M. de Jong, Nijmegen, Netherlands

► Watch now

View Abstract


OP037: Risk of cancer in Inflammatory Bowel Disease patients is associated with age and recent use of immunomodulators, while biologics and aminosalicylates are protective factors - a cross-sectional and follow-up analysis of the Swiss IBD cohort Study

T. Greuter, Zurich, Switzerland

► Watch now

View Abstract

 

Scientific session 12: ECCO Lecture

Is translation the way to treatment personalisation?

Yehuda Chowers, Haifa, Israel

► Watch now


Awards and closing remarks

Julián Panés, Barcelona, Spain

► Watch now